JCR Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 3/6
JCR Pharmaceuticals has a total shareholder equity of ¥57.0B and total debt of ¥28.4B, which brings its debt-to-equity ratio to 49.8%. Its total assets and total liabilities are ¥104.6B and ¥47.6B respectively.
Key information
49.8%
Debt to equity ratio
JP¥28.41b
Debt
| Interest coverage ratio | n/a |
| Cash | JP¥18.27b |
| Equity | JP¥57.05b |
| Total liabilities | JP¥47.57b |
| Total assets | JP¥104.62b |
Recent financial health updates
No updates
Recent updates
JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00
Sep 06
What JCR Pharmaceuticals Co., Ltd.'s (TSE:4552) 32% Share Price Gain Is Not Telling You
Sep 04JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00
Aug 23JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00
Aug 09Earnings Miss: JCR Pharmaceuticals Co., Ltd. Missed EPS By 90% And Analysts Are Revising Their Forecasts
Aug 03JCR Pharmaceuticals (TSE:4552) Will Pay A Dividend Of ¥10.00
Jul 26JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00
Jul 12JCR Pharmaceuticals Co., Ltd. (TSE:4552) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely
May 22JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00
Mar 18JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00
Feb 29Financial Position Analysis
Short Term Liabilities: 4552's short term assets (¥56.3B) exceed its short term liabilities (¥34.1B).
Long Term Liabilities: 4552's short term assets (¥56.3B) exceed its long term liabilities (¥13.4B).
Debt to Equity History and Analysis
Debt Level: 4552's net debt to equity ratio (17.8%) is considered satisfactory.
Reducing Debt: 4552's debt to equity ratio has increased from 27.8% to 49.8% over the past 5 years.
Debt Coverage: 4552's debt is not well covered by operating cash flow (16.5%).
Interest Coverage: Insufficient data to determine if 4552's interest payments on its debt are well covered by EBIT.